| Year |
Citation |
Score |
| 2023 |
Jing B, Qian Y, Heitjan DF, Xie H. Tutorial: Assessing the impact of nonignorable missingness on regression analysis using Index of Local Sensitivity to Nonignorability. Psychological Methods. PMID 37971833 DOI: 10.1037/met0000616 |
0.499 |
|
| 2023 |
Yun J, Filardo G, Ahuja V, Bowen ME, Heitjan DF. Predicting hospital readmission in Medicaid patients with diabetes using administrative and claims data. The American Journal of Managed Care. 29: e229-e234. PMID 37616150 DOI: 10.37765/ajmc.2023.89409 |
0.436 |
|
| 2023 |
Turer CB, Park JJ, Gupta OT, Ramirez C, Basit MA, Heitjan DF, Barlow SE. Electronic phenotypes to distinguish clinician attention to high body mass index, hypertension, lipid disorders, fatty liver and diabetes in pediatric primary care: Diagnostic accuracy of electronic phenotypes compared to masked comprehensive chart review. Pediatric Obesity. e13066. PMID 37458161 DOI: 10.1111/ijpo.13066 |
0.433 |
|
| 2023 |
Chen H, Heitjan DF. Sensitivity of estimands in clinical trials with imperfect compliance. The International Journal of Biostatistics. PMID 37365674 DOI: 10.1515/ijb-2022-0105 |
0.503 |
|
| 2022 |
Pruitt SL, Tavakkoli A, Zhu H, Heitjan DF, Gerber DE, Singal AG, Halm EA, Beg MS, Maddineni B, Kansagra AJ, Murphy CC. Survival of cancer survivors with a new pancreatic cancer diagnosis. Cancer Medicine. PMID 35674139 DOI: 10.1002/cam4.4903 |
0.486 |
|
| 2021 |
Balagopal A, Morgan H, Dohopolski M, Timmerman R, Shan J, Heitjan DF, Liu W, Nguyen D, Hannan R, Garant A, Desai N, Jiang S. PSA-Net: Deep learning-based physician style-aware segmentation network for postoperative prostate cancer clinical target volumes. Artificial Intelligence in Medicine. 121: 102195. PMID 34763810 DOI: 10.1016/j.artmed.2021.102195 |
0.454 |
|
| 2021 |
Chen X, Heitjan DF, Greil G, Jeon-Slaughter H. Estimating the optimal timing of surgery by imputing potential outcomes. Statistics in Medicine. PMID 34636065 DOI: 10.1002/sim.9217 |
0.491 |
|
| 2021 |
Chen H, Heitjan DF. Analysis of local sensitivity to nonignorability with missing outcomes and predictors. Biometrics. PMID 34297356 DOI: 10.1111/biom.13532 |
0.483 |
|
| 2021 |
Pruitt SL, Gerber DE, Zhu H, Heitjan DF, Maddineni B, Xiong D, Singal AG, Tavakkoli A, Halm EA, Murphy CC. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer. Cancer Medicine. PMID 34190429 DOI: 10.1002/cam4.4036 |
0.499 |
|
| 2021 |
Tsai S, Nguyen H, Ebrahimi R, Barbosa MR, Ramanan B, Heitjan DF, Hastings JL, Modrall JG, Jeon-Slaughter H. COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans. Scientific Reports. 11: 8497. PMID 33875764 DOI: 10.1038/s41598-021-88111-z |
0.464 |
|
| 2021 |
Pruitt SL, Zhu H, Heitjan DF, Rahimi A, Maddineni B, Tavakkoli A, Halm EA, Gerber DE, Xiong D, Murphy CC. Survival of women diagnosed with breast cancer and who have survived a previous cancer. Breast Cancer Research and Treatment. PMID 33620590 DOI: 10.1007/s10549-021-06122-w |
0.473 |
|
| 2020 |
Santen RJ, Heitjan DF, Gompel A, Lumsden MA, Pinkerton JV, Davis SR, Stuenkel CA. Approach to Managing a Postmenopausal Patient. The Journal of Clinical Endocrinology and Metabolism. PMID 32882039 DOI: 10.1210/Clinem/Dgaa623 |
0.491 |
|
| 2020 |
Begg CB, Gonen M, Heitjan DF. Editorial: Clinical trial design in the era of COVID-19. Clinical Trials (London, England). 1740774520940230. PMID 32650671 DOI: 10.1177/1740774520940230 |
0.517 |
|
| 2020 |
Chen X, Heitjan DF, Greil G, Jeon-Slaughter H. Estimating the optimal timing of surgery from observational data. Biometrics. PMID 32506431 DOI: 10.1111/Biom.13311 |
0.531 |
|
| 2020 |
Li S, Xie XJ, Heitjan DF. Flexible, rule-based dose escalation: The cohort-sequence design. Contemporary Clinical Trials Communications. 17: 100541. PMID 32099932 DOI: 10.1016/J.Conctc.2020.100541 |
0.528 |
|
| 2020 |
Santen RJ, Heitjan DF, Gompel A, Lumsden MA, Pinkerton JV, Davis SR, Stuenkel CA. Underlying breast cancer risk and menopausal hormone therapy. The Journal of Clinical Endocrinology and Metabolism. PMID 32052007 DOI: 10.1210/Clinem/Dgaa073 |
0.512 |
|
| 2020 |
Pruitt S, Gerber DE, Zhu H, Heitjan D, Maddineni B, Singal AG, Xiong D, Tavakkoli A, Halm E, Murphy CC. Survival among colorectal cancer patients with a history of previous cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E16146 |
0.525 |
|
| 2020 |
Pruitt S, Zhu H, Gerber DE, Heitjan D, Maddineni B, Xiong D, Halm E, Murphy CC. Survival among breast cancer patients with a history of previous cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E14080 |
0.531 |
|
| 2018 |
Lan Y, Tang G, Heitjan DF. Statistical modeling and prediction of clinical trial recruitment. Statistics in Medicine. PMID 30411375 DOI: 10.1002/Sim.8036 |
0.561 |
|
| 2018 |
Nath K, Roman J, Nelson DS, Guo L, Lee SC, Orlovskiy S, Muriuki K, Heitjan DF, Pickup S, Leeper DB, Blair IA, Putt ME, Glickson JD. Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin. Scientific Reports. 8: 14654. PMID 30279592 DOI: 10.1038/S41598-018-33019-4 |
0.513 |
|
| 2018 |
Xie H, Gao W, Xing B, Heitjan DF, Hedeker D, Yuan C. Measuring the Impact of Nonignorable Missingness Using the R Package isni. Computer Methods and Programs in Biomedicine. 164: 207-220. PMID 30195428 DOI: 10.1016/J.Cmpb.2018.06.014 |
0.508 |
|
| 2018 |
Santen RJ, Jewell CM, Yue W, Heitjan DF, Raff H, Katen KS, Cidlowski JA. Glucocorticoid receptor mutations and hypersensitivity to endogenous and exogenous glucocorticoids. The Journal of Clinical Endocrinology and Metabolism. PMID 30020469 DOI: 10.1210/Jc.2018-00352 |
0.473 |
|
| 2018 |
Mokdad AA, Xie XJ, Zhu H, Gerber DE, Heitjan DF. Statistical justification of expansion cohorts in phase 1 cancer trials. Cancer. PMID 29975406 DOI: 10.1002/Cncr.31577 |
0.55 |
|
| 2018 |
Ge Z, Heitjan DF, Gerber DE, Xuan L, Pruitt SL. Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers. Statistics in Medicine. PMID 29687467 DOI: 10.1002/Sim.7691 |
0.557 |
|
| 2018 |
Handorf EA, Heitjan DF, Bekelman JE, Mitra N. Estimating cost-effectiveness from claims and registry data with measured and unmeasured confounders. Statistical Methods in Medical Research. 962280218759137. PMID 29468944 DOI: 10.1177/0962280218759137 |
0.642 |
|
| 2018 |
Lan Y, Heitjan DF. Adaptive parametric prediction of event times in clinical trials. Clinical Trials (London, England). 1740774517750633. PMID 29376735 DOI: 10.1177/1740774517750633 |
0.537 |
|
| 2017 |
Mokdad AA, Yopp AC, Polanco PM, Mansour JC, Reznik SI, Heitjan DF, Choti MA, Minter RR, Wang SC, Porembka MR. Adjuvant Chemotherapy vs Postoperative Observation Following Preoperative Chemoradiotherapy and Resection in Gastroesophageal Cancer: A Propensity Score-Matched Analysis. Jama Oncology. PMID 28975352 DOI: 10.1001/Jamaoncol.2017.2805 |
0.534 |
|
| 2017 |
Ying GS, Zhang Q, Lan Y, Li Y, Heitjan DF. Cure Modeling in Real-Time Prediction: How Much Does It Help? Contemporary Clinical Trials. PMID 28545934 DOI: 10.1016/J.Cct.2017.05.012 |
0.556 |
|
| 2017 |
Heitjan DF. Commentary on Mason et al. Clinical Trials (London, England). 1740774517711443. PMID 28532162 DOI: 10.1177/1740774517711443 |
0.468 |
|
| 2017 |
Allen CM, Griffith SD, Shiffman S, Heitjan DF. Proximity and gravity: modeling heaped self-reports. Statistics in Medicine. PMID 28497551 DOI: 10.1002/Sim.7327 |
0.544 |
|
| 2017 |
O'Hara MH, Karasic TB, Vasilevskaya I, Redlinger M, Loaiza-Bonilla A, Teitelbaum UR, Giantonio BJ, Damjanov N, Reiss KA, Rosen MA, Heitjan DF, Troxel AB, Amaravadi RK, O'Dwyer PJ. Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer. Journal of Clinical Oncology. 35: 3545-3545. DOI: 10.1200/Jco.2017.35.15_Suppl.3545 |
0.577 |
|
| 2017 |
Bender S, Heitjan DF. Ignorability conditions for frequentist non parametric analysis of conditional distributions with incomplete data Communications in Statistics-Theory and Methods. 46: 5252-5264. DOI: 10.1080/03610926.2015.1099673 |
0.523 |
|
| 2016 |
Keefe SM, Hoffman-Censits J, Cohen RB, Mamtani R, Heitjan D, Eliasof S, Nixon A, Turnbull B, Garmey EG, Gunnarsson O, Waliki M, Ciconte J, Jayaraman L, Senderowicz A, Tellez AB, et al. Efficacy of the nanoparticle-drug conjugate CRLX101 in combination with bevacizumab in metastatic renal cell carcinoma: results of an investigator-initiated phase I-IIa clinical trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 27: 1579-85. PMID 27457310 DOI: 10.1093/Annonc/Mdw188 |
0.526 |
|
| 2016 |
Sterman DH, Alley E, Stevenson JP, Friedberg J, Metzger S, Recio A, Moon EK, Haas AR, Vachani A, Katz SI, Sun J, Heitjan D, Hwang WT, Litzky L, Yearley JH, et al. PILOT AND FEASIBILITY TRIAL OF IMMUNO-GENE THERAPY OF MALIGNANT MESOTHELIOMA USING INTRAPLEURAL DELIVERY OF ADENOVIRUS- INTERFERON-ALPHA COMBINED WITH CHEMOTHERAPY. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26968202 DOI: 10.1158/1078-0432.Ccr-15-2133 |
0.516 |
|
| 2016 |
Kaczmar JM, Tan KS, Heitjan DF, Lin A, Ahn PH, Newman JG, Rassekh CH, Chalian AA, O'Malley BW, Cohen RB, Weinstein GS. HPV-related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery. Head & Neck. 38: 59-65. PMID 25197014 DOI: 10.1002/Hed.23850 |
0.52 |
|
| 2015 |
Kennedy GT, Okusanya OT, Keating JJ, Heitjan DF, Deshpande C, Litzky LA, Albelda SM, Drebin JA, Nie S, Low PS, Singhal S. The Optical Biopsy: A Novel Technique for Rapid Intraoperative Diagnosis of Primary Pulmonary Adenocarcinomas. Annals of Surgery. 262: 602-9. PMID 26366539 DOI: 10.1097/Sla.0000000000001452 |
0.489 |
|
| 2015 |
Heitjan DF, Ge Z, Ying GS. Real-time prediction of clinical trial enrollment and event counts: A review. Contemporary Clinical Trials. 45: 26-33. PMID 26188165 DOI: 10.1016/J.Cct.2015.07.010 |
0.553 |
|
| 2015 |
Okusanya OT, DeJesus EM, Jiang JX, Judy RP, Venegas OG, Deshpande CG, Heitjan DF, Nie S, Low PS, Singhal S. Intraoperative molecular imaging can identify lung adenocarcinomas during pulmonary resection. The Journal of Thoracic and Cardiovascular Surgery. 150: 28-35.e1. PMID 26126457 DOI: 10.1016/J.Jtcvs.2015.05.014 |
0.501 |
|
| 2015 |
Griffith SD, Shiffman S, Li Y, Heitjan DF. Model-based imputation of latent cigarette counts using data from a calibration study. International Journal of Methods in Psychiatric Research. PMID 26081923 DOI: 10.1002/Mpr.1468 |
0.552 |
|
| 2015 |
Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Plos One. 10: e0128109. PMID 26010901 DOI: 10.1371/Journal.Pone.0128109 |
0.51 |
|
| 2015 |
Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, Porter DL, Vonderheide RH, Bagg A, Heitjan DF, Tsai DE, Reshef R. The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 25988622 DOI: 10.1111/Ajt.13324 |
0.527 |
|
| 2015 |
Hamilton DA, Mahoney MC, Novalen M, Chenoweth MJ, Heitjan DF, Lerman C, Tyndale RF, Hawk LW. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25732567 DOI: 10.1093/Ntr/Ntv031 |
0.518 |
|
| 2015 |
Nath K, Nelson DS, Heitjan DF, Zhou R, Leeper DB, Glickson JD. Effects of hyperglycemia on lonidamine-induced acidification and de-energization of human melanoma xenografts and sensitization to melphalan. Nmr in Biomedicine. 28: 395-403. PMID 25702942 DOI: 10.1002/Nbm.3260 |
0.527 |
|
| 2015 |
Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet. Respiratory Medicine. 3: 131-8. PMID 25588294 DOI: 10.1016/S2213-2600(14)70294-2 |
0.513 |
|
| 2015 |
Li Y, Mick R, Heitjan DF. Suspension of accrual in phase II cancer clinical trials. Clinical Trials (London, England). 12: 128-38. PMID 25568092 DOI: 10.1177/1740774514562029 |
0.55 |
|
| 2015 |
Nath K, Nelson DS, Heitjan DF, Leeper DB, Zhou R, Glickson JD. Lonidamine induces intracellular tumor acidification and ATP depletion in breast, prostate and ovarian cancer xenografts and potentiates response to doxorubicin. Nmr in Biomedicine. 28: 281-90. PMID 25504852 DOI: 10.1002/Nbm.3240 |
0.551 |
|
| 2015 |
DeMichele A, Clark AS, Tan KS, Heitjan DF, Gramlich K, Gallagher M, Lal P, Feldman M, Zhang P, Colameco C, Lewis D, Langer M, Goodman N, Domchek S, Gogineni K, et al. CDK 4/6 inhibitor palbociclib (PD0332991) in Rb+ advanced breast cancer: phase II activity, safety, and predictive biomarker assessment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 995-1001. PMID 25501126 DOI: 10.1158/1078-0432.Ccr-14-2258 |
0.523 |
|
| 2015 |
O'Hara MH, Gallagher M, Teitelbaum UR, Giantonio BJ, Damjanov N, Loaiza-Bonilla A, Amaravadi RK, Heitjan DF, Vasilevskaya I, Hoff DDV, Ramanathan RK, Laheru D, Jesus-Acosta AD, Velculescu VE, O'Dwyer PJ. Phase 1 trial of gemcitabine/nab-paclitaxel in combination with the autophagy inhibitor hydroxychloroquine in previously untreated patients with metastatic pancreatic adenocarcinoma. Journal of Clinical Oncology. 33. DOI: 10.1200/Jco.2015.33.15_Suppl.E15213 |
0.532 |
|
| 2015 |
Loaiza-Bonilla A, O'Hara MH, Redlinger M, Damjanov N, Teitelbaum UR, Vasilevskaya I, Rosen MA, Heitjan DF, Amaravadi RK, O'Dwyer PJ. Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer. Journal of Clinical Oncology. 33: 3614-3614. DOI: 10.1200/Jco.2015.33.15_Suppl.3614 |
0.542 |
|
| 2015 |
Sterman DH, Alley E, Friedberg J, Metzger S, Stevenson J, Moon E, Haas AR, Vachani A, Katz SI, Cheng G, Sun J, Heitjan DF, Litzky L, Cengel K, Simone CB, et al. Abstract B56: An immuno-gene therapy clinical trial evaluating in situ vaccination of malignant pleural mesothelioma with intrapleural delivery of adenovirus-interferon-alpha-2b in combination with chemotherapy Cancer Immunology Research. 3. DOI: 10.1158/2326-6074.Tumimm14-B56 |
0.566 |
|
| 2014 |
McCarthy AM, Kontos D, Synnestvedt M, Tan KS, Heitjan DF, Schnall M, Conant EF. Screening outcomes following implementation of digital breast tomosynthesis in a general-population screening program. Journal of the National Cancer Institute. 106. PMID 25313245 DOI: 10.1093/Jnci/Dju316 |
0.513 |
|
| 2014 |
Okusanya OT, Holt D, Heitjan D, Deshpande C, Venegas O, Jiang J, Judy R, DeJesus E, Madajewski B, Oh K, Wang M, Albelda SM, Nie S, Singhal S. Intraoperative near-infrared imaging can identify pulmonary nodules. The Annals of Thoracic Surgery. 98: 1223-30. PMID 25106680 DOI: 10.1016/J.Athoracsur.2014.05.026 |
0.478 |
|
| 2014 |
Rosenfeld MR, Ye X, Supko JG, Desideri S, Grossman SA, Brem S, Mikkelson T, Wang D, Chang YC, Hu J, McAfee Q, Fisher J, Troxel AB, Piao S, Heitjan DF, et al. A phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme. Autophagy. 10: 1359-68. PMID 24991840 DOI: 10.4161/Auto.28984 |
0.553 |
|
| 2014 |
Rangwala R, Leone R, Chang YC, Fecher LA, Schuchter LM, Kramer A, Tan KS, Heitjan DF, Rodgers G, Gallagher M, Piao S, Troxel AB, Evans TL, DeMichele AM, Nathanson KL, et al. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy. 10: 1369-79. PMID 24991839 DOI: 10.4161/Auto.29118 |
0.543 |
|
| 2014 |
Rangwala R, Chang YC, Hu J, Algazy KM, Evans TL, Fecher LA, Schuchter LM, Torigian DA, Panosian JT, Troxel AB, Tan KS, Heitjan DF, DeMichele AM, Vaughn DJ, Redlinger M, et al. Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma. Autophagy. 10: 1391-402. PMID 24991838 DOI: 10.4161/Auto.29119 |
0.556 |
|
| 2014 |
Vogl DT, Stadtmauer EA, Tan KS, Heitjan DF, Davis LE, Pontiggia L, Rangwala R, Piao S, Chang YC, Scott EC, Paul TM, Nichols CW, Porter DL, Kaplan J, Mallon G, et al. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy. 10: 1380-90. PMID 24991834 DOI: 10.4161/Auto.29264 |
0.543 |
|
| 2014 |
Padmanabhan RK, Somasundar VH, Griffith SD, Zhu J, Samoyedny D, Tan KS, Hu J, Liao X, Carin L, Yoon SS, Flaherty KT, Dipaola RS, Heitjan DF, Lal P, Feldman MD, et al. An active learning approach for rapid characterization of endothelial cells in human tumors. Plos One. 9: e90495. PMID 24603893 DOI: 10.1371/Journal.Pone.0090495 |
0.538 |
|
| 2014 |
Keefe SM, Heitjan D, Hennessey M, Robinson J, Mykulowicz K, Marshall A, Gunnarsson O, Mamtani R, Vaughn DJ, Hoffman-Censits JH, Nathanson KL, Lal P, Pryma DA, Eliasof S, Garmey EG, et al. Interim results of a phase 1b/2a study evaluating the nano pharmaceutical CRLX101 with bevacizumab (bev) in the treatment of patients (pts) with refractory metastatic renal cell carcinoma (mRCC). Journal of Clinical Oncology. 32: 412-412. DOI: 10.1200/Jco.2014.32.4_Suppl.412 |
0.541 |
|
| 2014 |
Hu B, Potluri A, Torigian DA, Heitjan DF, Nasta S, Schuster SJ, Svoboda J. Prognostic value of the maximum standardized uptake value of staging FDG-PET/CT in Hodgkin lymphoma. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E19552 |
0.511 |
|
| 2014 |
Clark AS, O'Dwyer PJ, Heitjan D, Lal P, Feldman MD, Gallagher M, Redlinger C, Colameco C, Lewis D, Zafman K, Langer M, Rosen MA, Gogineni K, Bradbury AR, Domchek SM, et al. A phase I trial of palbociclib and paclitaxel in metastatic breast cancer. Journal of Clinical Oncology. 32: 527-527. DOI: 10.1200/Jco.2014.32.15_Suppl.527 |
0.534 |
|
| 2013 |
Handorf EA, Bekelman JE, Heitjan DF, Mitra N. EVALUATING COSTS WITH UNMEASURED CONFOUNDING: A SENSITIVITY ANALYSIS FOR THE TREATMENT EFFECT. The Annals of Applied Statistics. 7: 2062-2080. PMID 24587844 DOI: 10.1214/13-Aoas665 |
0.634 |
|
| 2013 |
Schwed Lustgarten DE, Thompson J, Yu G, Vachani A, Vaidya B, Rao C, Connelly M, Udine M, Tan KS, Heitjan DF, Albelda S. Use of circulating tumor cell technology (CELLSEARCH) for the diagnosis of malignant pleural effusions. Annals of the American Thoracic Society. 10: 582-9. PMID 24236662 DOI: 10.1513/Annalsats.201303-068Oc |
0.504 |
|
| 2013 |
Stevenson JP, Kindler HL, Papasavvas E, Sun J, Jacobs-Small M, Hull J, Schwed D, Ranganathan A, Newick K, Heitjan DF, Langer CJ, McPherson JM, Montaner LJ, Albelda SM. Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients. Oncoimmunology. 2: e26218. PMID 24179709 DOI: 10.4161/Onci.26218 |
0.557 |
|
| 2013 |
Elkassabany N, Ahmed M, Malkowicz SB, Heitjan DF, Isserman JA, Ochroch EA. Comparison between the analgesic efficacy of transversus abdominis plane (TAP) block and placebo in open retropubic radical prostatectomy: a prospective, randomized, double-blinded study. Journal of Clinical Anesthesia. 25: 459-65. PMID 23965191 DOI: 10.1097/Sa.0000000000000068 |
0.513 |
|
| 2013 |
Santen RJ, Song Y, Yue W, Wang JP, Heitjan DF. Effects of menopausal hormonal therapy on occult breast tumors. The Journal of Steroid Biochemistry and Molecular Biology. 137: 150-6. PMID 23748149 DOI: 10.1016/J.Jsbmb.2013.05.008 |
0.543 |
|
| 2013 |
Santen RJ, Yue W, Heitjan DF. Occult breast tumor reservoir: biological properties and clinical significance. Hormones & Cancer. 4: 195-207. PMID 23632998 DOI: 10.1007/S12672-013-0145-Y |
0.551 |
|
| 2013 |
Sohal DP, Metz JM, Sun W, Giantonio BJ, Plastaras JP, Ginsberg G, Kochman ML, Teitelbaum UR, Harlacker K, Heitjan DF, Feldman MD, Drebin JA, O'Dwyer PJ. Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 71: 1485-91. PMID 23532207 DOI: 10.1007/S00280-013-2147-4 |
0.53 |
|
| 2013 |
Ying GS, Heitjan DF. Prediction of event times in the REMATCH Trial. Clinical Trials (London, England). 10: 197-206. PMID 23321264 DOI: 10.1177/1740774512470314 |
0.535 |
|
| 2013 |
Kang HC, Tan KS, Keefe SM, Heitjan DF, Siegelman ES, Flaherty KT, O'Dwyer PJ, Rosen MA. MRI assessment of early tumor response in metastatic renal cell carcinoma patients treated with sorafenib. Ajr. American Journal of Roentgenology. 200: 120-6. PMID 23255750 DOI: 10.2214/Ajr.12.8536 |
0.539 |
|
| 2013 |
Wileyto EP, Li Y, Chen J, Heitjan DF. Assessing the fit of parametric cure models. Biostatistics (Oxford, England). 14: 340-50. PMID 23197383 DOI: 10.1093/Biostatistics/Kxs043 |
0.562 |
|
| 2013 |
Nath K, Nelson DS, Ho AM, Lee SC, Darpolor MM, Pickup S, Zhou R, Heitjan DF, Leeper DB, Glickson JD. (31) P and (1) H MRS of DB-1 melanoma xenografts: lonidamine selectively decreases tumor intracellular pH and energy status and sensitizes tumors to melphalan. Nmr in Biomedicine. 26: 98-105. PMID 22745015 DOI: 10.1002/Nbm.2824 |
0.499 |
|
| 2013 |
DeMichele A, Clark AS, Heitjan D, Randolph S, Gallagher M, Lal P, Feldman MD, Zhang PJ, Schnader A, Zafman K, Domchek SM, Gogineni K, Keefe SM, Fox KR, O'Dwyer PJ. A phase II trial of an oral CDK 4/6 inhibitor, PD0332991, in advanced breast cancer. Journal of Clinical Oncology. 31: 519-519. DOI: 10.1200/Jco.2013.31.15_Suppl.519 |
0.546 |
|
| 2013 |
Clark A, Lal P, Tan K, Heitjan D, Feldman M, Zhang P, Gallagher M, Domchek S, Gogineni K, Keefe S, Fox K, O'Dwyer P, DeMichele A. Abstract P2-16-20: Biomarkers to predict response to the CDK 4/6 inhibitor, palbociclib (PD 0332991) in a single-agent phase II trial in advanced breast cancer Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-16-20 |
0.554 |
|
| 2013 |
Li Y, Heitjan DF. A note on the complementary mixture Pareto II distribution Communications in Statistics - Theory and Methods. 42: 201-213. DOI: 10.1080/03610926.2011.581787 |
0.5 |
|
| 2012 |
Wang H, Shiffman S, Griffith SD, Heitjan DF. Truth and Memory: Linking Instantaneous and Retrospective Self-Reported Cigarette Consumption. The Annals of Applied Statistics. 6: 1689-1706. PMID 24432181 DOI: 10.1214/12-Aoas557 |
0.532 |
|
| 2012 |
Liu T, Heitjan DF. Sensitivity of the discrete-time Kaplan-Meier estimate to nonignorable censoring: Application in a clinical trial. Statistics in Medicine. 31: 2998-3010. PMID 22806989 DOI: 10.1002/Sim.5454 |
0.566 |
|
| 2012 |
Reshef R, Luger SM, Hexner EO, Loren AW, Frey NV, Nasta SD, Goldstein SC, Stadtmauer EA, Smith J, Bailey S, Mick R, Heitjan DF, Emerson SG, Hoxie JA, Vonderheide RH, et al. Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. The New England Journal of Medicine. 367: 135-45. PMID 22784116 DOI: 10.1056/Nejmoa1201248 |
0.488 |
|
| 2012 |
Santen RJ, Yue W, Heitjan DF. Modeling of the growth kinetics of occult breast tumors: role in interpretation of studies of prevention and menopausal hormone therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1038-48. PMID 22586072 DOI: 10.1158/1055-9965.Epi-12-0043 |
0.534 |
|
| 2012 |
St Helen G, Novalen M, Heitjan DF, Dempsey D, Jacob P, Aziziyeh A, Wing VC, George TP, Tyndale RF, Benowitz NL. Reproducibility of the nicotine metabolite ratio in cigarette smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1105-14. PMID 22552800 DOI: 10.1158/1055-9965.Epi-12-0236 |
0.494 |
|
| 2012 |
Li Y, Mick R, Heitjan DF. A Bayesian approach for unplanned sample sizes in phase II cancer clinical trials. Clinical Trials (London, England). 9: 293-302. PMID 22523304 DOI: 10.1177/1740774512443429 |
0.546 |
|
| 2012 |
Tizon R, Frey N, Heitjan DF, Tan KS, Goldstein SC, Hexner EO, Loren A, Luger SM, Reshef R, Tsai D, Vogl D, Davis J, Vozniak M, Fuchs B, Stadtmauer EA, et al. High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. Bone Marrow Transplantation. 47: 1332-7. PMID 22307018 DOI: 10.1038/Bmt.2011.260 |
0.53 |
|
| 2012 |
Stevenson J, Kindler HL, Schwed D, Ranganathan A, Jacobs-Small M, Shouldis J, Marshall A, Heitjan D, Langer CJ, Hsu FJ, Albelda S. Phase II trial of anti-transforming growth factor-beta (TGFß) monoclonal antibody GC1008 in relapsed malignant pleural mesothelioma (MPM). Journal of Clinical Oncology. 30: 7077-7077. DOI: 10.1200/Jco.2012.30.15_Suppl.7077 |
0.55 |
|
| 2011 |
Heitjan DF. Incomplete data: what you don't know might hurt you. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1567-70. PMID 21750173 DOI: 10.1158/1055-9965.Epi-11-0505 |
0.516 |
|
| 2011 |
Christofidou-Solomidou M, Tyagi S, Tan KS, Hagan S, Pietrofesa R, Dukes F, Arguiri E, Heitjan DF, Solomides CC, Cengel KA. Dietary flaxseed administered post thoracic radiation treatment improves survival and mitigates radiation-induced pneumonopathy in mice. Bmc Cancer. 11: 269. PMID 21702963 DOI: 10.1186/1471-2407-11-269 |
0.497 |
|
| 2011 |
Sterman DH, Haas A, Moon E, Recio A, Schwed D, Vachani A, Katz SI, Gillespie CT, Cheng G, Sun J, Papasavvas E, Montaner LJ, Heitjan DF, Litzky L, Friedberg J, et al. A trial of intrapleural adenoviral-mediated Interferon-α2b gene transfer for malignant pleural mesothelioma. American Journal of Respiratory and Critical Care Medicine. 184: 1395-9. PMID 21642245 DOI: 10.1164/Rccm.201103-0554Cr |
0.542 |
|
| 2011 |
Li Y, Wileyto EP, Heitjan DF. Statistical analysis of daily smoking status in smoking cessation clinical trials. Addiction (Abingdon, England). 106: 2039-46. PMID 21631623 DOI: 10.1111/J.1360-0443.2011.03519.X |
0.509 |
|
| 2011 |
Vogl DT, Wang T, Pérez WS, Stadtmauer EA, Heitjan DF, Lazarus HM, Kyle RA, Kamble R, Weisdorf D, Roy V, Gibson J, Ballen K, Holmberg L, Bashey A, McCarthy PL, et al. Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 17: 1765-74. PMID 21624486 DOI: 10.1016/J.Bbmt.2011.05.005 |
0.509 |
|
| 2011 |
Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai de E. Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 11: 817-25. PMID 21401872 DOI: 10.1111/J.1600-6143.2011.03454.X |
0.492 |
|
| 2011 |
Li Y, Wileyto EP, Heitjan DF. Prediction of individual long-term outcomes in smoking cessation trials using frailty models. Biometrics. 67: 1321-9. PMID 21401566 DOI: 10.1111/J.1541-0420.2011.01578.X |
0.54 |
|
| 2011 |
Heitjan DF. Biology, models, and the analysis of tumor xenograft experiments. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 949-51. PMID 21224374 DOI: 10.1158/1078-0432.Ccr-10-3279 |
0.532 |
|
| 2011 |
Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Hadjiliadis D, Goral S, Krok KL, Goldberg LR, Porter DL, Stadtmauer EA, Tsai DE. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder(★). American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 11: 336-47. PMID 21219573 DOI: 10.1111/J.1600-6143.2010.03387.X |
0.544 |
|
| 2011 |
Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, Hershman DL, Neugut AI. Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers. Breast Cancer Research and Treatment. 125: 837-47. PMID 20644999 DOI: 10.1007/S10549-010-1043-4 |
0.522 |
|
| 2011 |
Reshef R, Luger SM, Hexner EO, Loren AW, Frey NV, Goldstein SC, Nasta SD, Stadtmauer EA, Smith J, Mick R, Heitjan DF, Hoxie JA, Emerson SG, Vonderheide RH, Porter DL. Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist – Final Results of a Phase I/II Study Blood. 118: 1011-1011. DOI: 10.1182/Blood.V118.21.1011.1011 |
0.528 |
|
| 2011 |
Reshef R, Luger S, Loren A, Frey N, Goldstein S, Hexner E, Stadtmauer E, Smith J, Mick R, Heitjan D, Hoxie J, Emerson S, Vonderheide R, Porter D. Feasibility, Safety and Efficacy of Maraviroc, a CCR5 Antagonist, in Graft-Versus-Host Disease Prevention After Reduced intensity Conditioned (RIC) Allogeneic Stem Cell Transplant (SCT): a Phase I/II Study Biology of Blood and Marrow Transplantation. 17: S331. DOI: 10.1016/J.Bbmt.2010.12.532 |
0.501 |
|
| 2011 |
Bellamy S, Heitjan DF, Weisberg E, Lin X. Guest Editor: Thomas R. Ten Have, Ph.D., M.P.H. (1958-2011) Statistics in Biosciences. 3: 1-2. DOI: 10.1007/S12561-011-9039-0 |
0.473 |
|
| 2010 |
Gastonguay MR, French JL, Heitjan DF, Rogers JA, Ahn JE, Ravva P. Missing data in model-based pharmacometric applications: points to consider. Journal of Clinical Pharmacology. 50: 63S-74S. PMID 20881220 DOI: 10.1177/0091270010378409 |
0.526 |
|
| 2010 |
Guo M, Heitjan DF. Multiplicity-calibrated Bayesian hypothesis tests. Biostatistics (Oxford, England). 11: 473-83. PMID 20212321 DOI: 10.1093/Biostatistics/Kxq012 |
0.525 |
|
| 2010 |
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and coronary heart disease: a systematic review and meta-analysis. Arthritis Care & Research. 62: 170-80. PMID 20191515 DOI: 10.1002/Acr.20065 |
0.485 |
|
| 2010 |
Mato AR, Luger SM, Heitjan DF, Mikkelsen ME, Olson E, Ujjani C, Jacobs S, Miltiades AN, Shah P, Schuster SJ, Carroll M, Chauffe AD, Fuchs BD. Elevation in serum lactate at the time of febrile neutropenia (FN) in hemodynamically-stable patients with hematologic malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biology & Therapy. 9: 585-9. PMID 20160493 DOI: 10.4161/Cbt.9.8.11270 |
0.516 |
|
| 2010 |
Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1374-82. PMID 20147892 DOI: 10.1038/Npp.2010.7 |
0.6 |
|
| 2010 |
Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Annals of Internal Medicine. 152: 144-51. PMID 20124230 DOI: 10.7326/0003-4819-152-3-201002020-00005 |
0.529 |
|
| 2010 |
Li Y, Wileyto EP, Heitjan DF. Modeling smoking cessation data with alternating states and a cure fraction using frailty models. Statistics in Medicine. 29: 627-38. PMID 20077505 DOI: 10.1002/Sim.3825 |
0.56 |
|
| 2010 |
Sterman DH, Recio A, Haas AR, Vachani A, Katz SI, Gillespie CT, Cheng G, Sun J, Moon E, Pereira L, Wang X, Heitjan DF, Litzky L, June CH, Vonderheide RH, et al. A phase I trial of repeated intrapleural adenoviral-mediated interferon-beta gene transfer for mesothelioma and metastatic pleural effusions. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 852-60. PMID 20068553 DOI: 10.1038/Mt.2009.309 |
0.527 |
|
| 2010 |
Fridlender ZG, Buchlis G, Kapoor V, Cheng G, Sun J, Singhal S, Crisanti MC, Crisanti C, Wang LC, Heitjan D, Snyder LA, Albelda SM. CCL2 blockade augments cancer immunotherapy. Cancer Research. 70: 109-18. PMID 20028856 DOI: 10.1158/0008-5472.Can-09-2326 |
0.528 |
|
| 2010 |
Grann VR, Patel PR, Jacobson JS, Warner E, Heitjan DF, Ashby-Thompson M, Hershman DL, Neugut AI. Comparative effectiveness of screening, surgery, and chemoprevention among BRCA1/2 mutation carriers. Journal of Clinical Oncology. 28: 6011-6011. DOI: 10.1200/Jco.2010.28.15_Suppl.6011 |
0.534 |
|
| 2010 |
Reshef R, Luger SM, Loren AW, Frey NV, Goldstein SC, Hexner EO, Stadtmauer EA, Smith J, Mick R, Heitjan DF, Shetzline SE, Danet-Desnoyers GH, Emerson SG, Hoxie JA, Vonderheide RH, et al. Prevention of Graft-Versus-Host Disease by Inhibition of Lymphocyte Trafficking Using a CCR5 Antagonist Blood. 116: 673-673. DOI: 10.1182/Blood.V116.21.673.673 |
0.542 |
|
| 2009 |
Griffith SD, Shiffman S, Heitjan DF. A method comparison study of timeline followback and ecological momentary assessment of daily cigarette consumption. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 1368-73. PMID 19808861 DOI: 10.1093/Ntr/Ntp150 |
0.503 |
|
| 2009 |
Mato A, Fuchs BD, Heitjan DF, Mick R, Halpern SD, Shah PD, Jacobs S, Olson EM, Schuster SJ, Ujjani C, Chong EA, Loren AW, Miltiades AN, Luger S. Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biology & Therapy. 8: 1095-1100. PMID 19652524 DOI: 10.4161/Cbt.8.12.8528 |
0.503 |
|
| 2009 |
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis and Rheumatism. 61: 885-92. PMID 19565556 DOI: 10.1002/Art.24612 |
0.486 |
|
| 2009 |
Carpenito C, Milone MC, Hassan R, Simonet JC, Lakhal M, Suhoski MM, Varela-Rohena A, Haines KM, Heitjan DF, Albelda SM, Carroll RG, Riley JL, Pastan I, June CH. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proceedings of the National Academy of Sciences of the United States of America. 106: 3360-5. PMID 19211796 DOI: 10.1073/Pnas.0813101106 |
0.505 |
|
| 2009 |
Xie H, Heitjan DF. Local Sensitivity to Nonignorability: Dependence on the Assumed Dropout Mechanism Statistics in Biopharmaceutical Research. 1: 243-257. DOI: 10.1198/Sbr.2009.0028 |
0.526 |
|
| 2009 |
Reshef R, Vardhanabhuti S, Luskin MR, Heitjan DF, Porter DL, Stadtmauer EA, Tsai DE. Reduction of Immunosuppression as Initial Therapy for Post-Transplantation Lymphoproliferative Disorder: Analysis of Efficacy, Safety and Prognostic Factors. Blood. 114: 103-103. DOI: 10.1182/Blood.V114.22.103.103 |
0.548 |
|
| 2009 |
Heitjan DF. Missing Data in Longitudinal Studies: Strategies for Bayesian Modeling and Sensitivity Analysis by DANIELS, M. J. and HOGAN, J. W Biometrics. 65: 328-328. DOI: 10.1111/J.1541-0420.2009.01208_2.X |
0.546 |
|
| 2008 |
Wallace A, Kapoor V, Sun J, Mrass P, Weninger W, Heitjan DF, June C, Kaiser LR, Ling LE, Albelda SM. Transforming growth factor-beta receptor blockade augments the effectiveness of adoptive T-cell therapy of established solid cancers. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 3966-74. PMID 18559619 DOI: 10.1158/1078-0432.Ccr-08-0356 |
0.5 |
|
| 2008 |
Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. A placebo-controlled trial of modafinil for nicotine dependence. Drug and Alcohol Dependence. 98: 86-93. PMID 18541389 DOI: 10.1016/J.Drugalcdep.2008.04.008 |
0.531 |
|
| 2008 |
Vira MA, Guzzo T, Heitjan DF, Tomaszewski JE, D'Amico A, Wein AJ, Malkowicz SB. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known? Bju International. 101: 1232-6. PMID 18419697 DOI: 10.1111/J.1464-410X.2008.07508.X |
0.523 |
|
| 2008 |
Wang H, Heitjan DF. Modeling heaping in self-reported cigarette counts. Statistics in Medicine. 27: 3789-804. PMID 18407584 DOI: 10.1002/Sim.3281 |
0.532 |
|
| 2008 |
Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment Pharmacogenomics Journal. 8: 391-399. PMID 18347612 DOI: 10.1038/Sj.Tpj.6500492 |
0.529 |
|
| 2008 |
Flaherty KT, Rosen MA, Heitjan DF, Gallagher ML, Schwartz B, Schnall MD, O'Dwyer PJ. Pilot study of DCE-MRI to predict progression-free survival with sorafenib therapy in renal cell carcinoma. Cancer Biology & Therapy. 7: 496-501. PMID 18219225 DOI: 10.4161/Cbt.7.4.5624 |
0.51 |
|
| 2008 |
Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 712-9. PMID 18165968 DOI: 10.1002/Ajmg.B.30669 |
0.541 |
|
| 2008 |
Ying GS, Heitjan DF. Weibull prediction of event times in clinical trials. Pharmaceutical Statistics. 7: 107-20. PMID 17377932 DOI: 10.1002/Pst.271 |
0.569 |
|
| 2008 |
Mato AR, Luger S, Loren AW, Heitjan DF, Olson ER, Ujjani CS, Jacobs S, Shah PD, Miltiades AN, Wang D, Lux K, Chong E, Belby LL, Tsai DE, Fuchs BD. Serum Lactic Acid (LA) as a Predictor of Septic Shock in Patients with Hematologic Malignancies (HM) Who Develop Febrile Neutropenia Blood. 112: 666-666. DOI: 10.1182/Blood.V112.11.666.666 |
0.524 |
|
| 2007 |
Donovan JM, Elliott MR, Heitjan DF. Predicting event times in clinical trials when randomization is masked and blocked. Clinical Trials (London, England). 4: 481-90. PMID 17942464 DOI: 10.1177/1740774507083390 |
0.537 |
|
| 2007 |
Sterman DH, Recio A, Carroll RG, Gillespie CT, Haas A, Vachani A, Kapoor V, Sun J, Hodinka R, Brown JL, Corbley MJ, Parr M, Ho M, Pastan I, Machuzak M, ... Heitjan DF, et al. A phase I clinical trial of single-dose intrapleural IFN-beta gene transfer for malignant pleural mesothelioma and metastatic pleural effusions: high rate of antitumor immune responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4456-66. PMID 17671130 DOI: 10.1158/1078-0432.Ccr-07-0403 |
0.525 |
|
| 2007 |
Zhang J, Heitjan DF. Impact of nonignorable coarsening on Bayesian inference. Biostatistics (Oxford, England). 8: 722-43. PMID 17215331 DOI: 10.1093/Biostatistics/Kxm001 |
0.569 |
|
| 2007 |
Mitra N, Heitjan DF. Sensitivity of the hazard ratio to nonignorable treatment assignment in an observational study. Statistics in Medicine. 26: 1398-414. PMID 16779876 DOI: 10.1002/Sim.2606 |
0.653 |
|
| 2007 |
Mato A, Fuchs B, Heitjan D, Olson E, Jacobs S, Mick R, Zheng D, Ujjani C, Miltiades A, Fabrega K, Morgans A, Carroll M, Loren A, Luger S. Systemic Inflammatory Response Syndrome (SIRS) as Predictor of Severe Sepsis (SS) in Hospitalized Patients (pts) with Hematologic Malignancies. Blood. 110: 633-633. DOI: 10.1182/Blood.V110.11.633.633 |
0.544 |
|
| 2006 |
Zhang J, Heitjan DF. A simple local sensitivity analysis tool for nonignorable coarsening: application to dependent censoring. Biometrics. 62: 1260-8. PMID 17156301 DOI: 10.1111/J.1541-0420.2006.00580.X |
0.557 |
|
| 2006 |
Mato AR, Riccio BE, Qin L, Heitjan DF, Carroll M, Loren A, Porter DL, Perl A, Stadtmauer E, Tsai D, Gewirtz A, Luger SM. A predictive model for the detection of tumor lysis syndrome during AML induction therapy. Leukemia & Lymphoma. 47: 877-83. PMID 16753873 DOI: 10.1080/10428190500404662 |
0.547 |
|
| 2006 |
Donovan JM, Elliott MR, Heitjan DF. Predicting event times in clinical trials when treatment arm is masked. Journal of Biopharmaceutical Statistics. 16: 343-56. PMID 16724489 DOI: 10.1080/10543400600609445 |
0.55 |
|
| 2006 |
Anderson K, Jacobson JS, Heitjan DF, Zivin JG, Hershman D, Neugut AI, Grann VR. Cost-effectiveness of preventive strategies for women with a BRCA1 or a BRCA2 mutation. Annals of Internal Medicine. 144: 397-406. PMID 16549852 DOI: 10.7326/0003-4819-144-6-200603210-00006 |
0.52 |
|
| 2006 |
Li H, Heitjan DF. A pattern-mixture model for the analysis of censored quality-of-life data. Statistics in Medicine. 25: 1533-46. PMID 16435338 DOI: 10.1002/Sim.2482 |
0.542 |
|
| 2006 |
Mato AR, Miltiades AN, Guo M, Heitjan DF, Carroll MP, Loren AW, Porter DL, Stadtmauer EA, Perl AE, Luger SM. Reproducibility of the Penn predictive score of tumor lysis syndrome (PPS-TLS) in acute myelogenous leukemia (AML) Journal of Clinical Oncology. 24: 6577-6577. DOI: 10.1200/Jco.2006.24.18_Suppl.6577 |
0.551 |
|
| 2006 |
Miltiades A, Mato A, Ujjani C, Carroll M, Bagg A, Heitjan D, Luger S. A Predictive Model for Cytogenetic Risk Group in Elderly AML: The Penn Cytogenetic Surrogate Score (PCSS). Blood. 108: 4446-4446. DOI: 10.1182/Blood.V108.11.4446.4446 |
0.544 |
|
| 2005 |
Zhang J, Heitjan DF. Nonignorable censoring in randomized clinical trials. Clinical Trials (London, England). 2: 488-96. PMID 16422309 DOI: 10.1191/1740774505Cn128Oa |
0.559 |
|
| 2005 |
Zhang J, Martins CR, Fansler ZB, Roemer KL, Kincaid EA, Gustafson KS, Heitjan DF, Clark DP. DNA methylation in anal intraepithelial lesions and anal squamous cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 6544-9. PMID 16166431 DOI: 10.1158/1078-0432.Ccr-05-0374 |
0.49 |
|
| 2005 |
Canter RJ, Kesmodel SB, Heitjan DF, Veeramachaneni NK, Mokadam NA, Drebin JA, Fraker DL. Suppression of beta-catenin by antisense oligomers augments tumor response to isolated limb perfusion in a rodent model of adenomatous polyposis coli-mutant colon cancer. Annals of Surgical Oncology. 12: 733-42. PMID 16132380 DOI: 10.1245/Aso.2005.10.005 |
0.518 |
|
| 2005 |
Ma G, Troxel AB, Heitjan DF. An index of local sensitivity to nonignorable drop-out in longitudinal modelling. Statistics in Medicine. 24: 2129-50. PMID 15909292 DOI: 10.1002/Sim.2107 |
0.674 |
|
| 2005 |
Gelman A, Van Mechelen I, Verbeke G, Heitjan DF, Meulders M. Multiple imputation for model checking: completed-data plots with missing and latent data. Biometrics. 61: 74-85. PMID 15737080 DOI: 10.1111/J.0006-341X.2005.031010.X |
0.632 |
|
| 2004 |
Xie H, Heitjan DF. Sensitivity analysis of causal inference in a clinical trial subject to crossover. Clinical Trials (London, England). 1: 21-30. PMID 16281459 DOI: 10.1191/1740774504Cn005Oa |
0.563 |
|
| 2004 |
Ying GS, Heitjan DF, Chen TT. Nonparametric prediction of event times in randomized clinical trials. Clinical Trials (London, England). 1: 352-61. PMID 16279273 DOI: 10.1191/1740774504Cn030Oa |
0.561 |
|
| 2004 |
Gustafson KS, Furth EE, Heitjan DF, Fansler ZB, Clark DP. DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimens: an approach that utilizes receiver-operating characteristic analysis. Cancer. 102: 259-68. PMID 15368319 DOI: 10.1002/Cncr.20425 |
0.49 |
|
| 2004 |
Heitjan DF, Kim CY, Li H. Bayesian estimation of cost-effectiveness from censored data. Statistics in Medicine. 23: 1297-309. PMID 15083484 DOI: 10.1002/Sim.1740 |
0.564 |
|
| 2004 |
Canter RJ, Zhou R, Kesmodel SB, Zhang Y, Heitjan DF, Glickson JD, Leeper DB, Fraker DL. Metaiodobenzylguanidine and hyperglycemia augment tumor response to isolated limb perfusion in a rodent model of human melanoma. Annals of Surgical Oncology. 11: 265-73. PMID 14993021 DOI: 10.1245/Aso.2004.05.019 |
0.513 |
|
| 2004 |
Heitjan DF, Li H. Bayesian estimation of cost-effectiveness: an importance-sampling approach. Health Economics. 13: 191-8. PMID 14737756 DOI: 10.1002/Hec.825 |
0.571 |
|
| 2004 |
Mato AR, Riccio BE, Qin L, Heitjan D, Loren A, Carroll M, Porter D, Tsai D, Stadtmauer E, Perl S, Gewirtz A, Nasta S, Schuster S, Goldstein S, Luger SM. A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia. Blood. 104: 883-883. DOI: 10.1182/Blood.V104.11.883.883 |
0.553 |
|
| 2003 |
Smith SJ, Neugut A, Heitjan D, Forde K, Holt P, Santella RM, Jiin-Chyuan L, Carney W, Ward L, Brandt-Rauf PW. In situ quantification of aberrant p53 in colorectal neoplasia. Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. 8: 311-32. PMID 12944180 DOI: 10.1080/1354750031000138676 |
0.525 |
|
| 2003 |
Savage DG, Cohen NS, Hesdorffer CS, Heitjan D, Oster MW, Garrett TJ, Bar M, del Prete S, March R, Lonberg M, Talbot S, Mears JG, Flamm M, Taub RN, Nichols G. Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia. Leukemia & Lymphoma. 44: 477-81. PMID 12688318 DOI: 10.1080/1042819021000046958 |
0.533 |
|
| 2002 |
Hripcsak G, Heitjan DF. Measuring agreement in medical informatics reliability studies. Journal of Biomedical Informatics. 35: 99-110. PMID 12474424 DOI: 10.1016/S1532-0464(02)00500-2 |
0.525 |
|
| 2002 |
Neugut AI, Fleischauer AT, Sundararajan V, Mitra N, Heitjan DF, Jacobson JS, Grann VR. Use of adjuvant chemotherapy and radiation therapy for rectal cancer among the elderly: a population-based study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2643-50. PMID 12039925 DOI: 10.1200/Jco.2002.08.062 |
0.642 |
|
| 2002 |
Grann VR, Jacobson JS, Thomason D, Hershman D, Heitjan DF, Neugut AI. Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2520-9. PMID 12011131 DOI: 10.1200/Jco.2002.10.101 |
0.537 |
|
| 2002 |
Chuang JH, Hripcsak G, Heitjan DF. Design and analysis of controlled trials in naturally clustered environments: implications for medical informatics. Journal of the American Medical Informatics Association : Jamia. 9: 230-8. PMID 11971884 DOI: 10.1197/Jamia.M0997 |
0.522 |
|
| 2002 |
Sundararajan V, Mitra N, Jacobson JS, Grann VR, Heitjan DF, Neugut AI. Survival associated with 5-fluorouracil-based adjuvant chemotherapy among elderly patients with node-positive colon cancer. Annals of Internal Medicine. 136: 349-57. PMID 11874307 DOI: 10.7326/0003-4819-136-5-200203050-00007 |
0.65 |
|
| 2002 |
Hershman D, Sundararajan V, Jacobson JS, Heitjan DF, Neugut AI, Grann VR. Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 9-16. PMID 11773148 DOI: 10.1200/Jco.20.1.9 |
0.545 |
|
| 2001 |
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, et al. Long-term use of a left ventricular assist device for end-stage heart failure. The New England Journal of Medicine. 345: 1435-43. PMID 11794191 DOI: 10.1056/Nejmoa012175 |
0.493 |
|
| 2001 |
Bagiella E, Heitjan DF. Predicting analysis times in randomized clinical trials Statistics in Medicine. 20: 2055-2063. PMID 11439420 DOI: 10.1002/Sim.843 |
0.558 |
|
| 2001 |
Mitra N, Schnabel FR, Neugut AI, Heitjan DF. Estimating the effect of an intensive surveillance program on stage of breast carcinoma at diagnosis: a propensity score analysis. Cancer. 91: 1709-15. PMID 11335895 DOI: 10.1002/1097-0142(20010501)91:9<1709::Aid-Cncr1188>3.0.Co;2-W |
0.621 |
|
| 2001 |
Hoh J, Heitjan DF, Mérette C, Ott J. Ascertainment and anticipation in family studies Human Heredity. 51: 23-26. PMID 11096267 DOI: 10.1159/000022955 |
0.516 |
|
| 2000 |
Savage DG, Rule SA, Tighe M, Garrett TJ, Oster MW, Lee RT, Ruiz J, Heitjan D, Keohan ML, Flamm M, Johnson SA. Gemcitabine for relapsed or resistant lymphoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 11: 595-7. PMID 10907954 DOI: 10.1023/A:1008307528519 |
0.512 |
|
| 2000 |
Heitjan DF. Fieller's method and net health benefits Health Economics. 9: 327-335. PMID 10862076 DOI: 10.1002/1099-1050(200006)9:4<327::Aid-Hec517>3.0.Co;2-S |
0.522 |
|
| 2000 |
Bagiella E, Sloan RP, Heitjan DF. Mixed-effects models in psychophysiology Psychophysiology. 37: 13-20. PMID 10705763 DOI: 10.1111/1469-8986.3710013 |
0.544 |
|
| 1999 |
Whang W, Sisk JE, Heitjan DF, Moskowitz AJ. Probabilistic sensitivity analysis in cost-effectiveness. An application from a study of vaccination against pneumococcal bacteremia in the elderly. International Journal of Technology Assessment in Health Care. 15: 563-72. PMID 10874382 DOI: 10.1017/S0266462399153108 |
0.51 |
|
| 1999 |
Antman KH, Heitjan DF, Hortobagyi GN. High-dose chemotherapy for breast cancer Journal of the American Medical Association. 282: 1701-1703. PMID 10568629 DOI: 10.1001/Jama.282.18.1701 |
0.559 |
|
| 1999 |
Heitjan DF. Ignorability and bias in clincial trials Statistics in Medicine. 18: 2421-2434. PMID 10474150 DOI: 10.1002/(Sici)1097-0258(19990915/30)18:17/18<2421::Aid-Sim266>3.0.Co;2-R |
0.553 |
|
| 1999 |
Heitjan DF. Causal inference in a clinical trial: A comparative example Controlled Clinical Trials. 20: 309-318. PMID 10440558 DOI: 10.1016/S0197-2456(99)00012-4 |
0.566 |
|
| 1999 |
Vitale MG, Krant JJ, Gelijns AC, Heitjan DF, Arons RR, Bigliani LU, Flatow EL. Geographic variations in the rates of operative procedures involving the shoulder, including total shoulder replacement, humeral head replacement, and rotator cuff repair Journal of Bone and Joint Surgery - Series A. 81: 763-772. PMID 10391541 DOI: 10.2106/00004623-199906000-00003 |
0.502 |
|
| 1999 |
Heitjan DF, Moskowitz AJ, Whang W. Bayesian estimation of cost-effectiveness ratios from clinical trials. Health Economics. 8: 191-201. PMID 10348414 DOI: 10.1002/(Sici)1099-1050(199905)8:3<191::Aid-Hec409>3.0.Co;2-R |
0.536 |
|
| 1999 |
Rose EA, Moskowitz AJ, Packer M, Sollano JA, Williams DL, Tierney AR, Heitjan DF, Meier P, Ascheim DD, Levitan RG, Weinberg AD, Stevenson LW, Shapiro PA, Lazar RM, Watson JT, et al. The REMATCH trial: rationale, design, and end points. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure. The Annals of Thoracic Surgery. 67: 723-30. PMID 10215217 DOI: 10.1016/S0003-4975(99)00042-9 |
0.508 |
|
| 1999 |
Shabisgh A, Tanji N, D’Agati V, Burchardt M, Rubin M, Goluboff ET, Heitjan D, Kiss A, Buttyan R. Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology. 140: 1920-1926. PMID 10098532 DOI: 10.1210/Endo.140.4.6644 |
0.498 |
|
| 1999 |
Hripcsak G, Kuperman GJ, Friedman C, Heitjan DF. A reliability study for evaluating information extraction from radiology reports Journal of the American Medical Informatics Association. 6: 143-150. PMID 10094067 DOI: 10.1136/Jamia.1999.0060143 |
0.509 |
|
| 1999 |
Grann VR, Whang W, Jacobson JS, Heitjan DF, Antman KH, Neugut AI. Benefits and costs of screening Ashkenazi Jewish women for BRCA1 and BRCA2 Journal of Clinical Oncology. 17: 494-500. PMID 10080590 DOI: 10.1200/Jco.1999.17.2.494 |
0.55 |
|
| 1999 |
Petrylak DP, Macarthur RB, O'Connor J, Shelton G, Judge T, Balog J, Pfaff C, Bagiella E, Heitjan D, Fine R, Zuech N, Sawczuk I, Benson M, Olsson CA. Phase I trial of docetaxel with estramustine in androgen-independent prostate cancer Journal of Clinical Oncology. 17: 958-967. PMID 10071290 DOI: 10.1200/Jco.1999.17.3.958 |
0.54 |
|
| 1999 |
Sollano JA, Gelijns AC, Moskowitz AJ, Heitjan DF, Cullinane S, Saha T, Chen JM, Roohan PJ, Reemtsma K, Shields EP. Volume-outcome relationships in cardiovascular operations: New York State, 1990-1995. The Journal of Thoracic and Cardiovascular Surgery. 117: 419-28; discussion 4. PMID 10047643 DOI: 10.1016/S0022-5223(99)70320-X |
0.438 |
|
| 1999 |
Goluboff ET, Shabsigh A, Saidi JA, Weinstein IB, Mitra N, Heitjan D, Piazza GA, Pamukcu R, Buttyan R, Olsson CA. Exisulind (sulindac sulfone) suppresses growth of human prostate cancer in a nude mouse xenograft model by increasing apoptosis. Urology. 53: 440-5. PMID 9933075 DOI: 10.1016/S0090-4295(98)00513-5 |
0.611 |
|
| 1999 |
Heitjan DF, Moskowitz AJ, Whang W. Problems with interval estimates of the incremental cost-effectiveness ratio. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 19: 9-15. PMID 9917015 DOI: 10.1177/0272989X9901900102 |
0.519 |
|
| 1998 |
Shabsigh A, Chang DT, Heitjan DF, Kiss A, Olsson CA, Puchner PJ, Buttyan R. Rapid reduction in blood flow to the rat ventral prostate gland after castration: Preliminary evidence that androgens influence prostate size by regulating blood flow to the prostate gland and prostatic endothelial cell survival Prostate. 36: 201-206. PMID 9687993 DOI: 10.1002/(Sici)1097-0045(19980801)36:3<201::Aid-Pros9>3.0.Co;2-J |
0.495 |
|
| 1998 |
Ennis RD, Malyszko BK, Heitjan DF, Rubin MA, O'Toole KM, Schiff PB. Changes in biochemical disease-free survival rates as a result of adoption of the consensus conference definition in patients with clinically localized prostate cancer treated with external-beam radiotherapy. International Journal of Radiation Oncology, Biology, Physics. 41: 511-7. PMID 9635696 DOI: 10.1016/S0360-3016(98)00104-7 |
0.533 |
|
| 1998 |
Goluboff ET, Saidi JA, Mazer S, Bagiella E, Heitjan DF, Benson MC, Olsson CA. Urinary continence after radical prostatectomy: The Columbia experience Journal of Urology. 159: 1276-1280. PMID 9507852 DOI: 10.1016/S0022-5347(01)63580-8 |
0.521 |
|
| 1998 |
Ennis RD, Malyszko BK, Rescigno J, Whitman AE, Heitjan DF, O'Toole KM, Rubin M, Schiff PB. Biologic classification as an alternative to anatomic staging for clinically localized prostate cancer: a proposal based on patients treated with external beam radiotherapy. Urology. 51: 265-70. PMID 9495709 DOI: 10.1016/S0090-4295(97)00503-7 |
0.532 |
|
| 1998 |
Heitjan DF. Book Review: The EM Algorithm and Extensions. Geoffrey J. McLachlan and Thriyambakam Krishnan, Wiley, New York, 1997. No. of pages: xvii+274. Price: $59.95. ISBN 0-471-12358-7 Statistics in Medicine. 17: 1187-1187. DOI: 10.1002/(Sici)1097-0258(19980530)17:10<1187::Aid-Sim849>3.0.Co;2-A |
0.472 |
|
| 1997 |
Goluboff ET, Heitjan DF, DeVries GM, Katz AE, Benson MC, Olsson CA. Pretreatment prostate specific antigen doubling times: Use in patients before radical prostatectomy Journal of Urology. 158: 1876-1879. PMID 9334621 DOI: 10.1016/S0022-5347(01)64154-5 |
0.529 |
|
| 1997 |
Heitjan DF. Bayesian interim analysis of phase II cancer clinical trials Statistics in Medicine. 16: 1791-1802. PMID 9280033 DOI: 10.1002/(Sici)1097-0258(19970830)16:16<1791::Aid-Sim609>3.0.Co;2-E |
0.547 |
|
| 1997 |
Ennis RD, Katz AE, De Vries GM, Heitjan DF, O'Toole KM, Rubin M, Buttyan R, Benson MC, Schiff PB. Detection of circulating prostate carcinoma cells via an enhanced reverse transcriptase-polymerase chain reaction assay in patients with early stage prostate carcinoma: Independence from other pretreatment characteristics Cancer. 79: 2402-2408. PMID 9191530 DOI: 10.1002/(Sici)1097-0142(19970615)79:12<2402::Aid-Cncr16>3.0.Co;2-V |
0.533 |
|
| 1997 |
Heitjan DF. Annotation: what can be done about missing data? Approaches to imputation American Journal of Public Health. 87: 548-550. PMID 9146428 DOI: 10.2105/AJPH.87.4.548 |
0.446 |
|
| 1997 |
Papadopoulos KP, Ayello J, Tugulea S, Heitjan DF, Williams C, Reiss RF, Vahdat LT, Suciu-Foca N, Antman KH, Hesdorffer CS. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support Journal of Hematotherapy. 6: 61-68. PMID 9112219 DOI: 10.1089/Scd.1.1997.6.61 |
0.521 |
|
| 1997 |
Heitjan DF, Sharma D. Modelling repeated-series longitudinal data Statistics in Medicine. 16: 347-355. PMID 9044525 DOI: 10.1002/(Sici)1097-0258(19970228)16:4<347::Aid-Sim423>3.0.Co;2-W |
0.551 |
|
| 1997 |
Heitjan DF. Ignorability, sufficiency and ancillarity Journal of the Royal Statistical Society. Series B: Statistical Methodology. 59: 375-381. DOI: 10.1111/1467-9868.00073 |
0.525 |
|
| 1996 |
Marcus LS, Hart D, Packer M, Yushak M, Medina N, Danziger RS, Heitjan DF, Katz SD. Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation. 94: 3184-9. PMID 8989127 DOI: 10.1161/01.Cir.94.12.3184 |
0.505 |
|
| 1996 |
Heitjan DF, Basu S. Distinguishing “Missing at Random” and “Missing Completely at Random” The American Statistician. 50: 207-213. DOI: 10.1080/00031305.1996.10474381 |
0.541 |
|
| 1995 |
Cataltepe O, Barron TF, Heitjan DF, Vannucci RC, Towfighi J. Effect of hypoxia/ischemia on bicuculline-induced seizures in immature rats: behavioral and electrocortical phenomena. Epilepsia. 36: 396-403. PMID 7607119 DOI: 10.1111/j.1528-1157.1995.tb01015.x |
0.423 |
|
| 1995 |
Masamura S, Santner SJ, Heitjan DF, Santen RJ. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells Journal of Clinical Endocrinology and Metabolism. 80: 2918-2925. PMID 7559875 DOI: 10.1210/Jcem.80.10.7559875 |
0.516 |
|
| 1995 |
Cataltepe O, Vannucci RC, Heitjan DF, Towfighi J. Effect of status epilepticus on hypoxic-ischemic brain damage in the immature rat. Pediatric Research. 38: 251-7. PMID 7478824 DOI: 10.1203/00006450-199508000-00019 |
0.447 |
|
| 1995 |
Heitjan DF. Bayesian analysis of a protocol for sampling preserved tumor specimens Journal of the American Statistical Association. 90: 38-44. DOI: 10.1080/01621459.1995.10476486 |
0.544 |
|
| 1994 |
Towfighi J, Housman C, Vannucci RC, Heitjan DF. Effect of unilateral perinatal hypoxic-ischemic brain damage on the gross development of opposite cerebral hemisphere. Biology of the Neonate. 65: 108-18. PMID 8173008 DOI: 10.1159/000244036 |
0.483 |
|
| 1994 |
Towfighi J, Housman C, Heitjan DF, Vannucci RC, Yager JY. The effect of focal cerebral cooling on perinatal hypoxic-ischemic brain damage. Acta Neuropathologica. 87: 598-604. PMID 8091953 DOI: 10.1007/Bf00293321 |
0.48 |
|
| 1994 |
Mujsce DJ, Towfighi J, Heitjan DF, Vannucci RC. Differences in intraischemic temperature influence neurological outcome after deep hypothermic circulatory arrest in newborn dogs. Stroke; a Journal of Cerebral Circulation. 25: 1433-41; discussion . PMID 8023360 |
0.429 |
|
| 1994 |
Sautter RL, Jones S, Weber DI, LeBar WD, Heitjan DF, Kopreski MMG, Gurcio FD. Prevalence of Hepatitis C Virus Antibody in Patients With Sexually Transmitted Diseases Attending a Harrisburg, PA, STD Clinic Infectious Diseases in Obstetrics and Gynecology. 1: 269-274. DOI: 10.1155/S1064744994000232 |
0.498 |
|
| 1994 |
Heitjan DF. Ignorability in general incomplete-data models Biometrika. 81: 701-708. DOI: 10.1093/Biomet/81.4.701 |
0.546 |
|
| 1994 |
Heitjan DF, Landis JR. Assessing secular trends in blood pressure: A multiple-imputation approach Journal of the American Statistical Association. 89: 750-759. DOI: 10.1080/01621459.1994.10476808 |
0.538 |
|
| 1993 |
Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing hypoxia-ischemia reduces brain injury in 7-day-old rats. Pediatric Research. 33: 405-11. PMID 8479823 DOI: 10.1203/00006450-199304000-00018 |
0.427 |
|
| 1993 |
Mawhinney H, Spector SL, Heitjan DF, Kinsman RA, Dirks JF, Pines I. As-needed medication use in asthma usage patterns and patient characteristics. Journal of Asthma. 30: 61-71. PMID 8428860 DOI: 10.3109/02770909309066381 |
0.501 |
|
| 1993 |
Heitjan DF. Ignorability and coarse data: Some biomedical examples Biometrics. 49: 1099-1109. PMID 8117903 DOI: 10.2307/2532251 |
0.551 |
|
| 1993 |
Smith PJ, Heitjan DF. Testing and Adjusting for Departures from Nominal Dispersion in Generalized Linear Models Applied Statistics. 42: 31-41. DOI: 10.2307/2347407 |
0.531 |
|
| 1992 |
Williams GD, Palmer C, Roberts RL, Heitjan DF, Smith MB. 31P NMR spectroscopy of perinatal hypoxic-ischemic brain damage: a model to evaluate neuroprotective drugs in immature rats. Nmr in Biomedicine. 5: 145-53. PMID 1642972 DOI: 10.1002/nbm.1940050308 |
0.447 |
|
| 1992 |
Heitjan DF, Derr JA, Satyaswaroop PG. The multi-site tumour transplantation model for human endometrial carcinoma: A statistical evaluation Cell Proliferation. 25: 193-203. PMID 1596532 DOI: 10.1111/j.1365-2184.1992.tb01394.x |
0.447 |
|
| 1992 |
Heitjan DF, Houts PS, Harvey HA. A decision-theoretic evaluation of early stopping rules Statistics in Medicine. 11: 673-683. PMID 1594809 DOI: 10.1002/Sim.4780110511 |
0.525 |
|
| 1992 |
Yager JY, Heitjan DF, Towfighi J, Vannucci RC. Effect of insulin-induced and fasting hypoglycemia on perinatal hypoxic-ischemic brain damage. Pediatric Research. 31: 138-42. PMID 1542541 DOI: 10.1203/00006450-199202000-00009 |
0.429 |
|
| 1992 |
Williams GD, Palmer C, Heitjan DF, Smith MB. Allopurinol preserves cerebral energy metabolism during perinatal hypoxia-ischemia: a 31P NMR study in unanesthetized immature rats. Neuroscience Letters. 144: 103-6. PMID 1436687 DOI: 10.1016/0304-3940(92)90726-N |
0.499 |
|
| 1991 |
Houts PS, Wojtkowiak SL, Simmonds MA, Weinberg GB, Heitjan DF. Using a state cancer registry to increase screening behaviors of sisters and daughters of breast cancer patients. American Journal of Public Health. 81: 386-8. PMID 1994751 DOI: 10.2105/Ajph.81.3.386 |
0.521 |
|
| 1991 |
Heitjan DF. Regression with bivariate grouped data Biometrics. 47: 549-562. PMID 1912261 DOI: 10.2307/2532145 |
0.532 |
|
| 1991 |
Heitjan DF. Generalized Norton-Simon models of tumour growth Statistics in Medicine. 10: 1075-1088. PMID 1876796 DOI: 10.1002/Sim.4780100708 |
0.542 |
|
| 1991 |
Heitjan DF, Little RJA. Multiple Imputation for the Fatal Accident Reporting System Applied Statistics. 40: 13. DOI: 10.2307/2347902 |
0.531 |
|
| 1991 |
Heitjan DF, Rubin DB. Ignorability and Coarse Data The Annals of Statistics. 19: 2244-2253. DOI: 10.1214/Aos/1176348396 |
0.612 |
|
| 1991 |
Heitjan DF. Nonlinear modeling of serial immunologic data: A case study Journal of the American Statistical Association. 86: 891-898. DOI: 10.1080/01621459.1991.10475129 |
0.56 |
|
| 1990 |
Wengrovitz M, Atnip RG, Gifford RRM, Neumyer MM, Heitjan DF, Thiele BL. Wound complications of autogenous subcutaneous infrainguinal arterial bypass surgery: Predisposing factors and management Journal of Vascular Surgery. 11: 156-163. PMID 2296096 DOI: 10.1016/0741-5214(90)90340-G |
0.441 |
|
| 1990 |
Gascho JA, Copenhaver GL, Heitjan DF. Systolic thickening increases from subepicardium to subendocardium Cardiovascular Research. 24: 777-780. PMID 2085832 DOI: 10.1093/Cvr/24.10.777 |
0.515 |
|
| 1990 |
Heitjan DF, Rubin DB. Inference from coarse data via multiple imputation with application to age heaping Journal of the American Statistical Association. 85: 304-314. DOI: 10.1080/01621459.1990.10476202 |
0.638 |
|
| 1990 |
Heitjan DF. Clinical cancer monographs. Vol. 2: Cancer of the larynx. Peter E. Robin, Jean Powell, Guy M. Holme el al., Macmillan Press, London, 1989. No. of pages: 238. Price: £D40 Statistics in Medicine. 9: 857-858. DOI: 10.1002/Sim.4780090720 |
0.515 |
|
| 1989 |
Ojo-Amaize E, Nishanian PG, Heitjan DF, Rezai A, Esmail I, Korns E, Detels R, Fahey J, Giorgi JV. Serum and effector-cell antibody-dependent cellular cytotoxicity (ADCC) activity remains high during human immunodeficiency virus (HIV) disease progression Journal of Clinical Immunology. 9: 454-461. PMID 2576558 DOI: 10.1007/Bf00918014 |
0.486 |
|
| 1989 |
Martínez-Maza O, Mitsuyasu RT, Miles SA, Giorgi JV, Heitjan DF, Sherwin SA, Fahey JL. γ-Interferon-induced monocyte major histocompatibility complex class II antigen expression in individuals with acquired immune deficiency syndrome Cellular Immunology. 123: 316-324. PMID 2507169 DOI: 10.1016/0008-8749(89)90292-X |
0.5 |
|
| 1989 |
Heitjan DF. [Inference from Grouped Continuous Data: A Review]: Rejoinder Statistical Science. 4: 182-183. DOI: 10.1214/Ss/1177012603 |
0.502 |
|
| 1989 |
Heitjan DF. Inference from Grouped Continuous Data: A Review Statistical Science. 4: 164-179. DOI: 10.1214/Ss/1177012601 |
0.524 |
|
| Show low-probability matches. |